ALEXION PHARMACEUTICALS, INC. reports

Company location: Boston, MA
Fiscal year end: 31 December

ALEXION PHARMACEUTICALS, INC. has filed 2,112 SEC EDGAR filings since 13 Jun 1996

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 526-550 of 1,000 matching filings.

Per page

25

Current page

22

4

FORM 4

Filing date: 14 Jun 2016
Reporting date: 13 Jun 2016
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 000-27756

8-K

Filing date: 06 Jun 2016
Reporting date: 06 Jun 2016
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

FORM 4

Filing date: 19 May 2016
Reporting date: 11 May 2016
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 18 May 2016
Reporting date: 16 May 2016
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 000-27756

8-K

Filing date: 16 May 2016
Reporting date: 11 May 2016
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 13 May 2016
Reporting date: 11 May 2016
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 13 May 2016
Reporting date: 11 May 2016
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 13 May 2016
Reporting date: 11 May 2016
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 13 May 2016
Reporting date: 11 May 2016
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 13 May 2016
Reporting date: 11 May 2016
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 13 May 2016
Reporting date: 11 May 2016
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 13 May 2016
Reporting date: 13 May 2016
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 13 May 2016
Reporting date: 13 May 2016
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 13 May 2016
Reporting date: 13 May 2016
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 13 May 2016
Reporting date: 11 May 2016
SEC evidence: Open document Open filing
Next action: Verify source filing

10-Q File 000-27756

10-Q

Filing date: 29 Apr 2016
Reporting date: 31 Mar 2016
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 000-27756

8-K

Filing date: 28 Apr 2016
Reporting date: 28 Apr 2016
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

UPLOAD

UPLOAD filing

Filing date: 06 Apr 2016
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 05 Apr 2016
Reporting date: 01 Apr 2016
SEC evidence: Open document Open filing
Next action: Verify source filing

DEFA14A File 000-27756

DEFA14A

Filing date: 31 Mar 2016
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

DEF 14A File 000-27756

DEFINITIVE NOTICE AND PROXY STATEMENT

Filing date: 31 Mar 2016
Reporting date: 31 Mar 2016
SEC evidence: Open document Open filing
Next action: Verify source filing

CORRESP

CORRESP filing

Filing date: 10 Mar 2016
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 04 Mar 2016
Reporting date: 02 Mar 2016
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 000-27756

8-K

Filing date: 03 Mar 2016
Reporting date: 26 Feb 2016
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 01 Mar 2016
Reporting date: 26 Feb 2016
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .